<DOC>
	<DOCNO>NCT01400191</DOCNO>
	<brief_summary>The aim study evaluate pharmacodynamic impact metformin healthy Caucasian volunteer without single polymorphism M420del R61C OCT1 , thus study hypothesis metformin affect hepatic gluconeogenesis healthy volunteer functional OCT1-transporters .</brief_summary>
	<brief_title>The Inhibitory Effect Metformin Gluconeogenesis Relation Polymorphisms Organic Cation Transporter 1</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy volunteer Written consent Genotyped OCT1 ( M420del R61C ) Daily medication Alcohol abuse Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Hypoglycemic Agents</keyword>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>Gluconeogenesis</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Pharmacogenetics</keyword>
</DOC>